These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7902973)

  • 1. Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide.
    Clements A; Walsh DM; Williams CH; Allsop D
    Neurosci Lett; 1993 Oct; 161(1):17-20. PubMed ID: 7902973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease.
    Clements A; Allsop D; Walsh DM; Williams CH
    J Neurochem; 1996 Feb; 66(2):740-7. PubMed ID: 8592147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's beta-amyloid peptide.
    El-Agnaf OM; Guthrie DJ; Walsh DM; Irvine GB
    Eur J Biochem; 1998 Sep; 256(3):560-9. PubMed ID: 9780232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein.
    Fraser PE; Nguyen JT; Inouye H; Surewicz WK; Selkoe DJ; Podlisny MB; Kirschner DA
    Biochemistry; 1992 Nov; 31(44):10716-23. PubMed ID: 1420187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.
    Wisniewski T; Ghiso J; Frangione B
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1247-54. PubMed ID: 1681804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
    Burdick D; Soreghan B; Kwon M; Kosmoski J; Knauer M; Henschen A; Yates J; Cotman C; Glabe C
    J Biol Chem; 1992 Jan; 267(1):546-54. PubMed ID: 1730616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.
    Wood SJ; Wetzel R; Martin JD; Hurle MR
    Biochemistry; 1995 Jan; 34(3):724-30. PubMed ID: 7827029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro.
    Fraser PE; Nguyen JT; McLachlan DR; Abraham CR; Kirschner DA
    J Neurochem; 1993 Jul; 61(1):298-305. PubMed ID: 8515277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
    Poduslo JF; Howell KG
    J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of amyloid fibril beta-peptide in familial Alzheimer's disease with APP717 mutations.
    Liepnieks JJ; Ghetti B; Farlow M; Roses AD; Benson MD
    Biochem Biophys Res Commun; 1993 Dec; 197(2):386-92. PubMed ID: 8267572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations.
    Seuma M; Faure AJ; Badia M; Lehner B; Bolognesi B
    Elife; 2021 Feb; 10():. PubMed ID: 33522485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
    McLaurin J; Fraser PE
    Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A beta A4 amyloid precursor protein gene and Alzheimer's disease.
    Hendriks L; Van Broeckhoven C
    Eur J Biochem; 1996 Apr; 237(1):6-15. PubMed ID: 8620894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.
    Wisniewski T; Ghiso J; Frangione B
    Biochem Biophys Res Commun; 1991 Nov; 180(3):1528. PubMed ID: 1953795
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered processing characteristics of beta-amyloid-containing peptides in cytosol and in media of familial Alzheimer's disease cells.
    Matsumoto A
    Biochim Biophys Acta; 1994 Feb; 1225(3):304-10. PubMed ID: 8312378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta/A4 peptide associated with Alzheimer's disease and cerebral amyloid angiopathy.
    Hirai S; Okamoto K
    Intern Med; 1993 Dec; 32(12):923-5. PubMed ID: 8204971
    [No Abstract]   [Full Text] [Related]  

  • 18. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide.
    Dudek SM; Johnson GV
    Brain Res; 1994 Jul; 651(1-2):129-33. PubMed ID: 7922559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations enhance the aggregation propensity of the Alzheimer's A beta peptide.
    Kim W; Hecht MH
    J Mol Biol; 2008 Mar; 377(2):565-74. PubMed ID: 18258258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
    Kim W; Hecht MH
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.